IMUX EBITDA | Immunic, Inc.

Immunic, Inc. (IMUX) EBITDA

2026-06-30: Basis Reported; EBITDA -$35.29M*; Operating income -$35.33M; Depreciation and amortization $34.00K*.
2026-03-31: Basis Reported; EBITDA -$33.2M; Operating income (m); Depreciation and amortization (m).
2025-12-31: Basis Reported; EBITDA -$23.29M; Operating income (m); Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA -$25.95M*; Operating income -$25.99M; Depreciation and amortization $40.00K*.

Complete source-backed ebitda history.

Available history: 2012-12-31 to 2026-03-31
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	-$35.29M*	-$35.33M	$34.00K*	(m)	(m)	$249.00K*	-$31.00M*	(m)	$25.93M	(m)	(m)
2026-03-31	Reported	-$33.2M	(m)	(m)	(m)	(m)	$2.00K	-$17.30M	(m)	$25.63M	(m)	(m)
2025-12-31	Reported	-$23.29M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2025-09-30	Reported	-$25.95M*	-$25.99M	$40.00K*	(m)	(m)	$67.00K*	-$20.14M*	(m)	$20.01M	(m)	(m)
2025-06-30	Reported	-$27.04M*	-$27.08M	$43.00K*	(m)	(m)	$36.00K*	-$24.61M*	(m)	$21.37M	(m)	(m)
2025-03-31	Reported	-$26.78M	(m)	(m)	(m)	(m)	$47.00K	-$21.78M	(m)	$21.53M	(m)	(m)
2024-12-31	Reported	-$25.6M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2024-09-30	Reported	-$25.68M*	-$25.73M	$42.00K*	(m)	(m)	$50.00K*	-$20.80M*	(m)	$21.37M	(m)	(m)
2024-06-30	Reported	-$22.78M*	-$22.81M	$31.00K*	(m)	(m)	$180.00K*	-$17.04M*	(m)	$18.32M	(m)	(m)
2024-03-31	Reported	-$23.86M	(m)	(m)	(m)	(m)	$31.00K	-$23.97M	(m)	$18.74M	(m)	(m)
2023-12-31	Reported	-$23.36M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2023-09-30	Reported	-$23.54M*	-$23.57M	$34.00K*	(m)	(m)	$44.00K*	-$17.31M*	(m)	$19.80M	(m)	(m)
2023-06-30	Reported	-$25.00M*	-$25.02M	$22.00K*	(m)	(m)	$21.00K*	-$19.98M*	(m)	$21.17M	(m)	(m)
2023-03-31	Reported	-$27.22M	(m)	(m)	(m)	(m)	$104.00K	-$19.51M	(m)	$22.96M	(m)	(m)
2022-12-31	Reported	-$57.31M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2022-09-30	Reported	-$20.10M*	-$20.12M	$17.00K*	(m)	(m)	$73.00K*	-$13.60M*	(m)	$16.54M	(m)	(m)
2022-06-30	Reported	-$20.59M*	-$20.61M	$20.00K*	(m)	(m)	$28.00K*	-$15.76M*	(m)	$16.54M	(m)	(m)
2022-03-31	Reported	-$21.41M	(m)	(m)	(m)	(m)	$12.00K	-$20.68M	(m)	$17.45M	(m)	(m)
2021-12-31	Reported	-$21.68M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2021-09-30	Reported	-$18.37M*	-$18.39M	$16.00K*	(m)	(m)	$20.00K*	-$17.60M*	(m)	$15.48M	(m)	(m)
2021-06-30	Reported	-$19.16M*	-$19.17M	$15.00K*	(m)	(m)	$18.00K*	-$29.00M*	(m)	$15.74M	(m)	(m)
2021-03-31	Reported	-$32.37M	(m)	(m)	(m)	(m)	$10.00K	-$12.95M	(m)	$11.52M	(m)	(m)
2020-12-31	Reported	-$14.21M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-09-30	Reported	-$13.50M*	-$13.54M	$43.00K*	(m)	(m)	$63.00K*	-$11.90M*	(m)	$11.04M	(m)	(m)
2020-06-30	Reported	-$12.22M*	-$12.22M	$6.00K*	(m)	(m)	$55.00K*	-$9.23M*	(m)	$9.99M	(m)	(m)
2020-03-31	Reported	-$9M	(m)	(m)	(m)	(m)	$4.00K	-$11.03M	(m)	$6.43M	(m)	(m)
2019-12-31	Reported	-$8.17M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-09-30	Reported	-$9.17M*	-$9.18M	$9.00K*	(m)	(m)	$13.00K*	-$5.98M*	(m)	$7.10M	(m)	(m)
2019-06-30	Reported	-$14.98M*	-$15.01M	$24.00K*	(m)	(m)	$10.00K*	-$10.99M*	(m)	$6.03M	(m)	(m)
2019-03-31	Reported	-$4.66M	(m)	(m)	(m)	(m)	$7.00K	-$5.32M	(m)	$3.35M	(m)	(m)
2018-12-31	Reported	-$5.23M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-09-30	Reported	-$1.6M	(m)	(m)	(m)	(m)	$5.00K*	(m)	(m)	$1.41M	(m)	(m)
2018-06-30	Reported	-$2.47M	(m)	(m)	(m)	(m)	-$143.00K*	(m)	(m)	$2.16M	(m)	(m)
2018-03-31	Reported	-$14.27M	(m)	(m)	(m)	(m)	$150.00K	-$13.07M	(m)	$10.16M	(m)	(m)
2017-12-31	Reported	-$14.56M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-09-30	Reported	-$12.42M	(m)	(m)	(m)	(m)	$169.00K*	(m)	(m)	$9.69M	(m)	(m)
2017-06-30	Reported	-$12.32M	(m)	(m)	(m)	(m)	$131.00K*	(m)	(m)	$9.83M	(m)	(m)
2017-03-31	Reported	-$12.35M	(m)	(m)	(m)	(m)	$274.00K	(m)	(m)	$9.63M	(m)	(m)
2016-12-31	Reported	-$11.42M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-09-30	Reported	-$9.82M	(m)	(m)	(m)	(m)	$272.00K*	(m)	(m)	$7.47M	(m)	(m)
2016-06-30	Reported	-$9.06M	(m)	(m)	(m)	(m)	$40.00K*	(m)	(m)	$6.86M	(m)	(m)
2016-03-31	Reported	-$9.16M	(m)	(m)	(m)	(m)	$125.00K	(m)	(m)	$6.86M	(m)	(m)
2015-12-31	Reported	-$9.51M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-09-30	Reported	-$12.01M	(m)	(m)	(m)	(m)	$312.00K*	(m)	(m)	$9.65M	(m)	(m)
2015-06-30	Reported	-$14.75M	(m)	(m)	(m)	(m)	$1.31M*	(m)	(m)	$11.54M	(m)	(m)
2015-03-31	Reported	-$14.52M	(m)	(m)	(m)	(m)	$674.00K	(m)	(m)	$11.75M	(m)	(m)
2014-12-31	Reported	-$13.78M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-09-30	Reported	-$12.5M	(m)	(m)	(m)	(m)	$320.00K*	(m)	(m)	$10.24M	(m)	(m)
2014-06-30	Reported	-$11.39M	(m)	(m)	(m)	(m)	$236.00K*	(m)	(m)	$9.13M	(m)	(m)
2014-03-31	Reported	-$11.58M	(m)	(m)	(m)	(m)	$809.00K	(m)	(m)	$9.22M	(m)	(m)
2013-12-31	Reported	-$10.02M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2013-09-30	Reported	-$8.91M	(m)	(m)	(m)	(m)	$619.00K*	(m)	(m)	$6.16M	(m)	(m)
2013-06-30	Reported	-$6.89M	(m)	(m)	(m)	(m)	$438.00K*	(m)	(m)	$4.54M	(m)	(m)
2013-03-31	Reported	-$4.76M	(m)	(m)	(m)	(m)	$120.00K	(m)	(m)	$3.43M	(m)	(m)

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	-$103.06M	(m)	(m)	(m)	(m)	$161.00K	-$85.81M	(m)	$81.98M	(m)	$0.00
2024-12-31	Reported	-$97.92M	(m)	(m)	(m)	(m)	$264.00K	-$84.77M	(m)	$80.05M	(m)	(m)
2023-12-31	Reported	-$99.11M	(m)	(m)	(m)	(m)	$334.00K	-$70.83M	(m)	$83.22M	(m)	(m)
2022-12-31	Reported	-$119.41M	(m)	(m)	(m)	(m)	$112.00K	-$65.14M	(m)	$71.25M	(m)	(m)
2021-12-31	Reported	-$91.58M	(m)	(m)	(m)	(m)	$67.00K	-$83.23M	(m)	$61.12M	(m)	(m)
2020-12-31	Reported	-$48.93M	(m)	(m)	(m)	(m)	$146.00K	-$46.12M	(m)	$38.64M	(m)	(m)
2019-12-31	Reported	-$36.98M	(m)	(m)	(m)	(m)	$55.00K	-$28.55M	(m)	$22.51M	(m)	(m)
2018-12-31	Reported	-$11.98M	(m)	(m)	(m)	(m)	$32.00K	-$9.74M	(m)	$9.60M	(m)	(m)
2017-12-31	Reported	-$51.66M	(m)	(m)	(m)	(m)	$685.00K	-$40.40M	(m)	$39.34M	(m)	(m)
2016-12-31	Reported	-$39.46M	(m)	(m)	(m)	(m)	$556.00K	-$35.77M	(m)	$30.05M	(m)	(m)
2015-12-31	Reported	-$50.79M	(m)	(m)	(m)	(m)	$2.34M	(m)	(m)	$39.77M	(m)	(m)
2014-12-31	Reported	-$49.26M	(m)	(m)	(m)	(m)	$1.41M	(m)	(m)	$39.48M	(m)	(m)
2013-12-31	Reported	-$30.6M	(m)	(m)	(m)	(m)	$1.48M	(m)	(m)	$21.79M	(m)	(m)
2012-12-31	Reported	-$8.93M	(m)	(m)	(m)	(m)	$261.00K	(m)	(m)	$5.10M	(m)	(m)

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
INOVIO PHARMACEUTICALS, INC. (INO)	United States	$0.125B	-1.35
MEDICINOVA INC (MNOV)	United States	$0.130B	-6.04
NRX Pharmaceuticals, Inc. (NRXP)	United States	$0.131B	-6.31
Aardvark Therapeutics, Inc. (AARD)	United States	$0.121B	-1.80
CUMBERLAND PHARMACEUTICALS INC (CPIX)	United States	$0.121B	-8.95
Coya Therapeutics, Inc. (COYA)	United States	$0.121B	-6.35
Unicycive Therapeutics, Inc. (UNCY)	United States	$0.134B	-3.70
TuHURA Biosciences, Inc./NV (HURA)	United States	$0.134B	-4.88
OnKure Therapeutics, Inc. (OKUR)	United States	$0.119B	-3.13
Curanex Pharmaceuticals Inc (CURX)	United States	$0.138B